BioNTech Completes Acquisition of Kite's Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, Maryland Biotech Investing
Gilead Sciences Endows Its Foundation With More Than $200 Million to Support Health Justice, Community Giving and Employee Match Program Biotech Investing
Bristol Myers Squibb Completes Sale of Manufacturing Facility in Couvet, Switzerland Biotech Investing
Bristol Myers Squibb Receives European Commission Approval for Opdivo as Adjuvant Treatment for Esophageal or Gastroesophageal Junction Cancer Patients with Residual Pathologic Disease Following Chemoradiotherapy Biotech Investing
